SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Cybercab and robotaxi momentum is driving attention, with Teslas Texas fleet additions and upcoming launch event fueling bullish FSD, autonomy and short-squeeze speculation. Traders remain divided, with some expecting continued momentum while others view the event as a sell-the-news catalyst and question Teslas valuation, execution and robotaxi capabilities.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Hawkish Federal Reserve messaging, elevated oil-driven inflation risks and heavy government borrowing are keeping long-term Treasury yields high, pressuring TLT. Traders are divided between expecting further weakness as rate-hike odds rise and betting that Treasury buybacks could spark a short-term bond rally, while skeptics say the intervention does not address the underlying fiscal strain.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

GTA VI gameplay leaks and reaction to its extended preview are driving attention, with traders debating whether the footage signals a weaker, delayed, or less monetizable launch. Bulls view the leaks as outdated publicity and continue buying the dip, while bears cite potential performance, PC-release, and GTA Online concerns as reasons for the selloff.

Edison International is a renewable energy company, which operates through its subsidiaries. It supplies and distributes electric power, and also invests in energy services and technologies. The company was founded on July 4, 1886, and is headquartered in Rosemead, CA.

Edison International

California wildfire legislation failed to provide the liability protections investors expected, leaving Edison International exposed to potentially significant wildfire claims and prompting analyst downgrades and a sharp selloff. Traders are split between viewing the move as an overreaction and dividend-driven buying opportunity versus fearing prolonged legal, credit, and dividend risk if liability remains uncapped.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Weak quarterly results, slowing monetization, a projected bookings decline, and the withdrawal of full-year guidance have driven a sharp repricing in Roblox shares. Traders are divided between viewing the selloff as an overreaction and bounce opportunity, or expecting further downside as analyst downgrades and uncertainty over growth and profitability weigh on sentiment.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Attention is centered on Structure Therapeutics oral GLP-1 obesity program, including upcoming Phase 3 and amylin data catalysts. Traders are also speculating that the company could attract a partnership or buyout from big pharma, although no transaction has been confirmed and some debate the drugs tolerability, liver-safety risks, and competitive positioning.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Q2 earnings have put ROOT in focus, with traders debating strong profitability and share buybacks against flat revenue and declining policies in force after marketing reductions. Bulls view the low valuation, cash generation, and potential Hyundai, New Jersey, and other distribution partnerships as support, while bears argue the weakening growth profile makes the stock a value trap.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

Better-than-expected quarterly results, a raised fiscal outlook, and multiple analyst upgrades have fueled renewed enthusiasm around MongoDBs Atlas cloud database and potential AI/agentic workloads. Traders remain divided, with bulls citing improving growth and enterprise demand while skeptics question the valuation and focus on the unusually sharp post-earnings swings and options-driven volatility.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

A broad post-SpaceX IPO reset and Planet Labs large ATM offering have driven a steep selloff, with traders citing capital rotation away from other space names, weak momentum, and dilution concerns. The community is split between bearish views that the stock needs a strong earnings report or new contracts to recover and bullish investors focused on its backlog, defense/AI demand, and potential for a turnaround.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing attention after quarterly results triggered a sharp selloff over an earnings miss, despite stronger revenue, raised full-year guidance, and a record backlog tied to power, grid, and AI data-center demand. Traders are divided between viewing the reaction as an overreaction and buying opportunity versus warning that valuation, wind-segment losses, tariffs, and execution risks justify further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN FRANCISCO, Aug. 28, 2026 SAN FRANCISCO, Aug. 28, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today...

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in...

Nektar Q2 Earnings Beat Estimates, Revenues Lag, Pipeline in Focus

NKTR's Q2 earnings beat estimates, but revenues fall short. Investor focus stays on rezpeg as late-stage studies advance in autoimmune diseases.

Retail Sales Weaken in July

U.S. Stock Futures Mixed, Heads for a Winning Week

U.S. Stock Futures Mixed, Heads for a Winning Week.

Full Transcript: Nektar Therapeutics Q2 2026 Earnings Call

Nektar Therapeutics (NASDAQ:NKTR) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

Nektar Therapeutics (NKTR) Reports Q2 Loss, Misses Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of +40.29% and -6.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nektar Therapeutics Announces Second Quarter 2026 Financial Results

Nektar Therapeutics Announces Second Quarter 2026 Financial Results Nektar Therapeutics Announces Second Quarter 2026 Financial Results PR Newswire SAN FRANCISCO, Aug. 13, 2026 SAN FRANCISCO, Aug. 13, 2026 /PRNewswire/ -- Nektar Therapeutics(Nasdaq: NKTR), a clinical-stage biotechnology company...

Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of 0.00% and -1.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm

Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm PR Newswire NEW YORK, Aug. 11, 2026 NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating...

• Reported GAAP EPS of -$1.23 up 58.31% YoY
• Reported revenue of $10.13M down -9.34% YoY

Nektar Therapeutics faces significant risks from its high dependency on the success of rezpegaldesleukin, substantial future capital requirements, and reliance on third-party partners for critical clinical trial execution.

Nektar Therapeutics initiated Phase 3 registrational trials for rezpegaldesleukin, demonstrated long-term durability in clinical studies, and maintains a strong cash position of over $1 billion to fund future operations.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

NKTR Stock Clocks Best Day In Over 2 Months As Investors Await Upcoming Clinical Data In Eczema

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NKTR Nektar Therapeutics

Fundamentals

Connect Stocktwits to ChatGPT

Latest NKTR News